Events

SEARCH EVENTS

events April 5, 2026

Ivan Wasserman and Jennifer Adams to Speak at AHPA Strengthening Dietary Supplement Claims Webinar

Ivan Wasserman and Jennifer Adams will join the roster of speakers presenting at AHPA’s webinar, “Strengthening Dietary Supplement Claims: Evidence, Expectations & Enforcement,” on April 28 – 29, 2026.

events March 27, 2026

FROM CONCEPT TO CLINIC: The Realities of Planning and Running Medical Device Clinical Studies In the U.S.

An Exclusive Webinar APRIL 28, 2026 2:00-3:00 PM ET

events January 21, 2026

Bob Durkin to Speak at 5th Scientific Kratom Symposium

Bob Durkin has joined the faculty of the 5th Scientific Kratom Symposium, which will be held Feb. 17-20 in Orlando, FL.

events January 21, 2026

Jennifer Adams and Bob Durkin Join CPG Legal Forum Faculty

Jennifer Adams and Bob Durkin have been invited to speak at the 2026 CPG Legal Forum in Frisco, TX, February 18-20.

events January 9, 2026

Rend Al-Mondhiry to Speak at UNPA Expert Insights Virtual Meeting

On January 22, 2026, Rend Al-Mondhiry will co-present “Clinical Trials 2.0: Building the Future of Evidence in the Natural Products Industry.”

events January 9, 2026

Ivan Wasserman to Speak at IPA World Congress + Probiota 2026

Ivan Wasserman has joined the roster of thought leaders who will be speaking at the IPA World Congress + Probiota 2026 in Dublin, Ireland, February 11 -13, 2026.

events January 2, 2026

New Webinar Hosted by Naturally Chicago: Litigation and Regulatory Trends Update

Join us for a free webinar on Tuesday, Jan. 13, hosted and moderated by Naturally Chicago‘s Jim Slama.

events November 1, 2025

Ivan Wasserman to Give Keynote at Plug and Play Silicon Valley Summit

Ivan Wasserman will serve as the keynote speaker at Plug and Play’s Silicon Valley Summit in Sunnyvale, CA, November 18-20, 2025.

What's Now

Ivan Wasserman Quoted in “FDA Shakeup: Makary Steps Down, Diamantas Steps Up”

In its coverage of the leadership shakeup at FDA and the appointment of a new commissioner, NutraIngredients turned to Ivan Wasserman for comment.

see all news >